Oral human papillomavirus infection incidence and clearance: A systematic review of the literature

Journal of General Virology

Volumn 98, Issue 4, 2017, Pages 519-526

  Wood, Zoe C ^a   Bain, Christopher J ^a   Smith, David D ^a   Whiteman, David C ^a   Antonsson, Annika ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Clearance; Incidence; Oral human papillomavirus (HPV) infections; Prevalence; Risk factors; Squamous cell carcinoma of the head and neck

Indexed keywords

VIRUS DNA;

HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INCIDENCE; MOUTH INFECTION; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; VIRAL CLEARANCE; WART VIRUS; CLASSIFICATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MOUTH DISEASES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIROLOGY;

DNA, VIRAL; GENOTYPE; HUMANS; INCIDENCE; MOUTH DISEASES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 85019116890     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000727     Document Type: Review

References (31)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–19.
2. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342–350.
3. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92:709–720.
4. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E et al. Human pap-illomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125–1131.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–2917.
6. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–1956.
7. Hocking JS, Stein A, Conway EL, Regan D, Grulich A et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 2011;104:886–891.
8. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M et al. Inci-dence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362–366.
9. Gillison ML, D’Souza G, Westra W, Sugar E, Xiao W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407–420.
10. Beachler DC, Sugar EA, Margolick JB, Weber KM, Strickler HD et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol 2015;181:40–53.
11. Kero K, Rautava J, Syrjänen K, Willberg J, Grenman S et al. Smoking increases oral HPV persistence among men: 7-year fol-low-up study. Eur J Clin Microbiol Infect Dis 2014;33:123–133.
12. Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR et al. Incidence and clearance of oral human papillomavirus infec-tion in men: the HIM cohort study. Lancet 2013;382:877–887.
13. Louvanto K, Rautava J, Willberg J, Wideman L, Syrjänen K et al. Genotype-specific incidence and clearance of human papillomavi-rus in oral mucosa of women: a six-year follow-up study. PLoS One 2013;8:e53413.
14. Pierce Campbell CM, Kreimer AR, Lin HY, Fulp W, O’Keefe MT et al. Long-term persistence of oral human papillomavirus type16: the HPV Infection in Men (HIM) study. Cancer Prev Res 2015;8: 190–196.
15. Rautava J, Willberg J, Louvanto K, Wideman L, Syrjänen K et al. Prevalence, genotype distribution and persistence of human papil-lomavirus in oral mucosa of women: a six-year follow-up study. PLoS One 2012;7:e42171.
16. Rintala M, Grénman S, Puranen M, Syrjänen S. Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV family study. J Clin Virol 2006;35:89–94.
17. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96:449–455.
18. Pickard RK, Xiao W, Broutian TR, He X, Gillison ML. The preva-lence and incidence of oral human papillomavirus infection among young men and women, aged 18–30 years. Sex Transm Dis 2012;39:559–566.
19. Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q et al.Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis 2012;39:860–867.
20. Hong AM, Grulich AE, Jones D, Lee CS, Garland SM et al. Squa-mous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010; 28:3269–3272.
21. King EM, Oomeer S, Gilson R, Copas A, Beddows S et al. Oral human papillomavirus infection in men who have sex with men: a systematic review and meta-analysis. PLoS One 2016;11: e0157976. systematic review and meta-analysis. PLoS One 2016;11: e0157976.
22. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W et al. Preva-lence of oral HPV infection in the United States, 2009–2010. JAMA 2012;307:693–703.
23. Kreimer AR, Villa A, Nyitray AG, Abrahamsen M, Papenfuss M et al. The epidemiology of oral HPV infection among a multina-tional sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011;20:172–182.
24. Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH et al. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 2007;26:836–840.
25. Antonsson A, Cornford M, Perry S, Davis M, Dunne MP et al. Prev-alence and risk factors for oral HPV infection in young Austral-ians. PLoS One 2014;9:e91761.
26. Esquenazi D, Bussoloti Filho I, Carvalho Mda G, Barros FS. The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR. Braz J Otorhinolaryngol 2010; 76:78–84.
27. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB et al. Strong association between infection with human papillo-mavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:1337–1344.
28. D’Souza G, Sugar E, Ruby W, Gravitt P, Gillison M. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol 2005;43:5526–5535.
29. Clifford GM, Vaccarella S, Franceschi S, Tenet V, Umulisa MC et al. Comparison of two widely-used HPV detection and genotyp-ing methods: GP5+/6+ PCR followed by reverse line blot hybrid-ization and multiplex type-specific E7 PCR. J Clin Microbiol 2016;54:2031–2038.
30. Fuessel Haws AL, He Q, Rady PL, Zhang L, Grady J et al. Nested PCR with the PGMY09/11 and GP5+/6 + primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 2004; 122:87–93.
31. Fakhry C, Rosenthal BT, Clark DP, Gillison ML. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res 2011;4:1378–1384.